Amphotericin B encapsulated in liposomes administered to cancer patients.
Meunier
F
F
Service de Médecine Interne, Centre des Tumeurs de l'Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium.
Sculier
J P
JP
Coune
A
A
Brassinne
C
C
Heyman
C
C
Laduron
C
C
Collette
N
N
Hollaert
C
C
Bron
D
D
Klastersky
J
J
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy*; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008081:Liposomes / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*
D008081:Liposomes; D010743:Phospholipids; D000666:Amphotericin B